Fundraising Fox
/Companies
Sign in

AtheroMed

Acquired

Menlo Park, US · 3 known investors

Find your way into AtheroMed

Sign up to see every warm intro you have to AtheroMed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AtheroMed team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Acquired by Volcano Corporation June 2014 · $130M ($115 million cash at closing plus up to $15 million milestone payment) · source ↗

AtheroMed was a Menlo Park medical device company that developed the Phoenix Atherectomy System, a catheter-based device to mechanically remove arterial plaque in peripheral artery disease patients.

Healthtech

Founders & leadership

CD
Chris DanekFounder
WM
Will McGuireExecutive

Board

DS
David SchulteBoard director
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
AK
Alan KaganovBoard director
TC
Tony ChouBoard director

Investors · 3

Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M

How we know: Kaiser Permanente Ventures's portfolio page · Not right? Tell us

US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10M

How we know: US Venture Partners's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4.5M disclosed across 1 round · 2012

▶$4.5MraisedMar 2012 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris DanekExecutive Officer
  • Will McGuireExecutive Officer, Director
  • David SchulteDirector
  • Casey TanseyDirector
  • Alan KaganovDirector
  • Tony ChouDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Mar 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does AtheroMed do?
AtheroMed was a Menlo Park medical device company that developed the Phoenix Atherectomy System, a catheter-based device to mechanically remove arterial plaque in peripheral artery disease patients.
Who founded AtheroMed?
AtheroMed was founded by Chris Danek.
Who are AtheroMed's investors?
AtheroMed's investors include Canaan Partners, Kaiser Permanente Ventures, US Venture Partners.
How much funding has AtheroMed raised?
AtheroMed has disclosed $4.5M raised across 1 round.
Where is AtheroMed headquartered?
AtheroMed is headquartered in Menlo Park, US.